Skip to main content

Advertisement

Log in

Crystal Structure of a Rearranged Cage Compound, 3-Hydroxy-4-aza-8-oxoheptacyclo [9.4.1.02,10.03,14.04,9.09,13.012,15]tetradecane

  • Original Paper
  • Published:
Journal of Chemical Crystallography Aims and scope Submit manuscript

Abstract

Polycyclic hydrocarbon compounds exhibit a wide variety of biological activities, ranging from antiviral to Parkinson’s disease. Several structures such as the adamantanes have reached clinical status and are used therapeutically to treat, amongst others, neurodegenerative disorders such as Alzheimer’s. Polycyclics have also been utilised as carrier molecules to facilitate entry of drugs into the brain. The synthesis, molecular and crystal structure of a new polycyclic compound, 3-hydroxy-4-aza-8-oxoheptacyclo[9.4.1.02,10.03,14.04,9.09,13.012,15]tetradecane, are reported. NMR spectroscopy was applied for structure elucidation of the novel compound and a rearrangement mechanism is proposed for its formation. This compound crystallises in the orthorhombic system, space group Pbca (no. 61). The unit cell parameters are: a = 12.3763 (7), b = 11.6597 (6), c = 15.0539 (8) Å, V = 2172.3 (2) Å3 , and Z = 8 molecules in the unit cell. The reported structure was confirmed by X-ray analysis, which showed that the title molecules associate into centrosymmetric dimers via N–H···O hydrogen bonding.

Index Abstract

The synthesis and structure of a new polycyclic compound, 3-hydroxy-4-aza-8-oxoheptacyclo[9.4.1.02,10.03,14.04,9.09,13.012,15]tetradecane, are reported in this article.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Scheme 1
Fig. 1
Fig. 2
Scheme 2
Fig. 3

Similar content being viewed by others

References

  1. Pardridge WM (2001) Brain drug targeting; Cambridge University Press, New York, 347 pp

    Google Scholar 

  2. Geldenhuys WJ, Malan SF, Bloomquist JR, Marchand AP, Van Der Schyf CJ (2005) Med Res Rev 25:21–48

    Article  CAS  Google Scholar 

  3. Tsuzuki N, Hama T, Kawada M, Hasui A, Konishi R, Shiwa S, Ochi Y, Futaki S, Kitagawa K 1994 J Pharm Sci 83:481–484

    Article  CAS  Google Scholar 

  4. Zah J, Terre’Blanche G, Erasmus E, Malan SF (2003) Bioorg Med Chem 11:3569–3578

    Article  CAS  Google Scholar 

  5. Geldenhuys WJ, Terre’Blanche G, Van Der Schyf CJ, Malan SF (2003) Eur J Pharmacol 458:73–79

    Article  CAS  Google Scholar 

  6. Geldenhuys WJ, Malan SF, Bloomquist JR, Van Der Schyf CJ (2007) Bioorg Med Chem 15:1525–1532

    Article  CAS  Google Scholar 

  7. Van Der Schyf CJ, Geldenhuys WJ, Youdim MBH (2006) Drugs fut 31:447–460

    Article  Google Scholar 

  8. McMurry J (2000) Organic chemistry, 5th edn. Brooks/Cole, Pacific Grove, 1284 pp

    Google Scholar 

Download references

Acknowledgements

Financial assistance from the National Research Foundation (South Africa) is thankfully acknowledged. MRC thanks the University of Cape Town for research support.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sarel F. Malan.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Prins, L.H.A., de Vries, A., Caira, M.R. et al. Crystal Structure of a Rearranged Cage Compound, 3-Hydroxy-4-aza-8-oxoheptacyclo [9.4.1.02,10.03,14.04,9.09,13.012,15]tetradecane. J Chem Crystallogr 38, 705–709 (2008). https://doi.org/10.1007/s10870-008-9381-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10870-008-9381-3

Keywords

Navigation